tapebrief
Preliminary brief— based on press release only. Full analysis including management tone and Q&A will be added when the transcript is available.

BF.B · Q2 2026 Earnings

Brown–Forman

Reported December 4, 2025

30-second summary

30-second take: Q2 reported net sales fell 5% YoY to $1.036B (-2% organic) with GAAP EPS of $0.47 and reported operating margin of 29.4% (-170bps YoY from 31.1%). Management reaffirmed FY26 organic sales and operating income at low-single-digit declines but cut FY26 capex from $125–135M to $110–120M — a ~10% reduction at the midpoint that signals defensive capital allocation rather than confidence in a H2 reacceleration. H1 organic trends show Tequila at -3%, the U.S. flat (reported -9%), and "Rest of Portfolio" organic at +22% (reported -35% on Korbel/Sonoma-Cutrer/Finlandia lapping) — and management explicitly told investors they are "not in a place where we are narrowing our top line range."

Headline numbers

EPS

Q2 FY2026

$0.47

Revenue

Q2 FY2026

$1.04B

-5.0% YoY

Gross margin

Q2 FY2026

59.3%

Free cash flow

Q2 FY2026

$0.24B

Operating margin

Q2 FY2026

29.4%

Key financials

Q2 FY2026
MetricQ2 FY2026YoYQ1 FY2026QoQ
Revenue$1.04B-5.0%$0.92B+12.1%
EPS$0.47$0.36+30.6%
Gross margin59.3%59.8%-50bps
Operating margin29.4%28.2%+120bps
Free cash flow$0.24B$0.13B+82.9%

Guidance

Company reaffirms low-single digit organic sales and operating income declines for FY2026 while cutting capital expenditure guidance by ~10%, signaling cautious capital allocation amid persistent macroeconomic headwinds.

Guidance is issued for both next quarter and the full year. Both may appear below.

Changes to prior guidance

MetricPeriodPrior guideNew guideΔResult
Capital expenditures
FY 2026
$125 to $135 million$110 to $120 million-$15 to -$5 million (midpoint -$12.5M)Lowered

Reaffirmed unchanged this quarter: Organic net sales growth (low-single digit decline), Organic operating income growth (low-single digit decline), Effective tax rate (approximately 21% to 23%)

Platform metrics

Q2 FY2026
SegmentQ2 FY2026
Jack Daniel's Tennessee Whiskey (JDTW) depletions6.6 million 9-liter cases
New Mix depletions6.0 million 9-liter cases
Jack Daniel's RTD/RTP depletions5.1 million 9-liter cases
Herradura depletions0.3 million 9-liter cases
New Mix organic growth30% organic
Gin Mare organic growth33% organic

Profitability

Q2 FY2026
SegmentQ2 FY2026
Operating margin29.4%

Other KPIs

Q2 FY2026
SegmentQ2 FY2026
Free cash flow$236 million

Management tone

Q4 FY25 "year unlike any other" reset → Q1 FY26 "structural pushback + execution defense" → Q2 FY26 "defensive stability, no narrowing"

Management's framing of the environment hardened from "cyclical headwinds easing over time" to explicit acknowledgment that headwinds may persist. The verbatim shift — "we expect cyclical headwinds to ease over time while also acknowledging…some current headwinds may persist over time" — is the second consecutive quarter where Whiting has had to walk back the cyclical-recovery timeline. Combined with the capex cut, the signal is that the team is no longer underwriting a near-term inflection and is instead reorganizing the cost and investment base around the possibility that the current environment is the operating environment.

The distributor transition narrative completed its arc from "managed and phased" (Q4 FY25) to "system will settle down" (Q1 FY26) to "transitions now complete; focus shifted from transition to execution" this quarter. The anchor quote — "we've loaded in a lot of our initial inventory for the Jack Daniels, Tennessee BlackBerry launch and our new distributors in the U.S. that should now begin to normalize in our second half" — confirms that H2 U.S. shipments are explicitly being managed toward depletion pace, which mechanically caps any FY26 upside from inventory build.

The used-barrel headwind, flagged as a temporary cyclical issue two quarters ago, has now hardened into a structural drag. Cunningham this quarter said used-barrel organic net sales decreased "more than 60%" with the Scotch/Irish whiskey industry pressure "continuing" — and the FY26 expectation that used barrel sales remain "more than half" below FY25 levels has not improved. This is no longer a one-year reset; it is an open-ended margin headwind with no recovery timeline disclosed.

The most telling line was Whiting's framing of the quarter itself: "it seemed like a boring quarter. But in a lot of ways, it was because, one, we've had a lot of volatility in the last couple of years, and that seems to be slowing down a bit." This is management defending against the expectation of acceleration by reframing stability as the new positive case. Combined with the explicit refusal to narrow the top-line range — "with the volatility that continues to be in the marketplace…we're not in a place where we are narrowing" — the posture is one of preserving optionality rather than committing to a trajectory.

The full-year guide credibility test from last quarter resolved with the response being to cut capex rather than reaffirm growth investment — confirming that management is prioritizing cash preservation over reinvestment despite reaffirming the organic decline guide.

Recurring themes management leaned on this quarter:

Emerging markets resilience masking developed market weaknessJack Daniels Tennessee BlackBerry as sole near-term growth catalyst with shipment normalization aheadU.S. distributor transitions complete but requiring inventory normalization in H2Persistent macro uncertainty limiting visibility and forcing expense disciplineFree cash flow improvement via lower capex and inventory reductionCyclical vs. structural demand debate unresolved; GLP-1 headwind still future risk

Risks management surfaced:

Canada tariff headwind persisting full fiscal year with no recovery assumptionTDS (total distilled spirits) category continuing low single-digit decline with potential accelerationGLP-1 drugs as emerging structural demand threat to spirits consumptionTrade-down in premium segments ($50+) accelerating if macro deteriorates furtherNew Mix comping tough year-ago double-digit growth in H2, moderating emerging market growthUsed barrel sales down 60%+ with industry-wide Scotch/Irish whiskey distress

Answers to last quarter's watch list

H2 shipment-vs-depletion gap — Management explicitly framed Q2 as the start of inventory normalization for the JDTB launch and new distributors, with U.S. depletion-based results (+3%) running ahead of takeaway (-3%) but expected to converge. The "shipments will roughly equal depletions" commitment was reaffirmed verbatim. Status: Resolved as expected
Tequila durability at +1% organic — Did not hold. H1 Tequila organic was -3%, with Herradura -11% organic. The Q1 print does look like it was phasing-aided by el Jimador shipments ahead of the 13-state distributor transitions, exactly as flagged.
Resolved negatively
Jack Daniel's family depletions trajectory — H1 JDTW depletions of 6.6M cases (-5%), JD RTD/RTP 5.1M (-4%). With Whiskey segment organic flat at 0%, the Tennessee Blackberry layering is offsetting underlying decline rather than driving growth.
Continue monitoring
Canada revenue trajectory — Canada H1 organic net sales declined 61%. Management's qualitative framing reiterated that the Canada tariff headwind persists for the full fiscal year with no recovery assumption.
Not resolved
Full-year guide credibility — Guide reaffirmed with capex cut alongside explicit refusal to narrow the top-line range — strong evidence that management is positioning for continued pressure rather than acceleration. Status: Resolved with defensive posture

What to watch into next quarter

Q3 U.S. organic trajectory: H1 U.S. organic was flat, with reported -9% reflecting A&D. Watch whether the depletion-based +3% vs. takeaway -3% gap narrows as JDTB shipment phasing ends and the new distributor terms benefit annualizes.

Tequila Q3 organic: H1 organic at -3% means the +1% Q1 stabilization was phasing. Watch whether el Jimador and Herradura prints get any worse, or whether H1 was the trough.

New Mix / emerging comp moderation: Emerging organic at +12% in H1 (vs. +25% Q1 standalone) remains the only material growth pocket. Watch whether the deceleration continues into Q3 against tough year-ago comps.

Used-barrel revenue stabilization: the >60% H1 decline has now persisted with no disclosed recovery timeline. Watch for any sequential improvement or further degradation; the FY26 "more than half below FY25" framing is the floor management has committed to.

Capex run-rate: with FY26 capex cut to $110–120M, watch H2 capex actuals to gauge whether the cut is investment deferral (recoverable) or structural (signals further demand caution into FY27).

Sources

  1. Brown-Forman FY26 Q2 press release: https://www.sec.gov/Archives/edgar/data/14693/000001469325000107/fy26_q2xerevergreen.htm
  2. H1 depletion figures (JDTW 6.6M, JD RTD/RTP 5.1M, New Mix 6.0M) sourced from Schedule B of the press release
  3. Tapebrief prior coverage: BF.B Q1 FY2026 and Q4 FY2025 briefs

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.